Zhengye Biotechnology Holding (ZYBT) Cash & Equivalents (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Cash & Equivalents of $7.1 million for Q4 2025, up 173.98% year-over-year from $2.6 million in Q4 2024, and up 11.48% quarter-over-quarter from $6.4 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Cash & Equivalents (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Cash & Equivalents for 3 consecutive years, with $7.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Equivalents rose 173.98% year-over-year to $7.1 million; the TTM figure through Dec 2025 stood at $7.1 million (up 173.98% YoY), while the FY2025 annual figure was $7.2 million, up 170.46% from the prior year.
- Cash & Equivalents improved to $7.1 million in Q4 2025 per ZYBT's latest filing, from $6.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $7.1 million in Q4 2025 and bottomed at $2.6 million in Q4 2024.
- Historically, Cash & Equivalents has averaged $5.0 million across 3 years, with a median of $5.1 million in 2023.
- Annual changes were most pronounced in 2024 — Cash & Equivalents slumped 31.4% — and 2025, when it soared 173.98%.
- Zhengye Biotechnology Holding's Cash & Equivalents stood at $3.8 million in 2023, then plunged by 31.4% to $2.6 million in 2024, then jumped by 173.98% to $7.1 million in 2025.
- Business Quant data shows ZYBT's Cash & Equivalents at $7.1 million in Q4 2025, $6.4 million in Q2 2025, and $2.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Zhengye Biotechnology Holding | 88.07 Mn | 80.75 Mn | - | 7.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.10 Mn |
| Jun 30, 2025 | 6.37 Mn |
| Dec 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 3.78 Mn |